Handbook of Multiple Myeloma
Handbook of Multiple Myeloma

Author: Mohamad Mohty

Publisher: Springer

Published: 2015-07-14

Total Pages: 109

ISBN-13: 3319182188

DOWNLOAD EBOOK

This handbook is an in-depth and comprehensive guide to the pathophysiology, diagnosis, staging, treatment and management of patients with multiple myeloma. The Handbook was commissioned to address an unmet need for a book of this kind in the myeloma field and to provide busy healthcare professionals with an informative and educational review of the current and emerging treatment recommendations for multiple myeloma. Myeloma is a type of bone marrow cancer arising from plasma cells and is the second most common form of bone marrow cancer, but represents just 1% of all cancers. The causes of myeloma are not fully understood but it is thought to be caused by an interaction of both genetic and environmental factors. This Handbook discusses these issues as well the latest developments in the field and will be an invaluable source of topical information for all healthcare professionals with an interest in multiple myeloma.

Multiple Myeloma
Multiple Myeloma

Author: Robert J. Heller

Publisher: Woolaston Press

Published: 2004-08-01

Total Pages: 141

ISBN-13: 0965700534

DOWNLOAD EBOOK

A comprehensive handbook and guide in easy to understand terms dealing with Multiple Myeloma; the disease, treatments, medications, lifestyle changes, and resources. Written by a non-medical author and based upon personal experiences. Updated annually.

The EBMT/EHA CAR-T Cell Handbook
The EBMT/EHA CAR-T Cell Handbook

Author: Nicolaus Kröger

Publisher: Springer Nature

Published: 2022-02-07

Total Pages: 221

ISBN-13: 3030943534

DOWNLOAD EBOOK

This first open access European CAR-T Handbook, co-promoted by the European Society for Blood and Marrow Transplantation (EBMT) and the European Hematology Association (EHA), covers several aspects of CAR-T cell treatments, including the underlying biology, indications, management of side-effects, access and manufacturing issues. This book, written by leading experts in the field to enhance readers’ knowledge and practice skills, provides an unparalleled overview of the CAR-T cell technology and its application in clinical care, to enhance readers’ knowledge and practice skills.

Handbook of Statistics in Clinical Oncology
Handbook of Statistics in Clinical Oncology

Author: John Crowley

Publisher: CRC Press

Published: 2005-12-01

Total Pages: 642

ISBN-13: 142002776X

DOWNLOAD EBOOK

A compendium of cutting-edge statistical approaches to solving problems in clinical oncology, Handbook of Statistics in Clinical Oncology, Second Edition focuses on clinical trials in phases I, II, and III, proteomic and genomic studies, complementary outcomes and exploratory methods. Cancer Forum called the first edition a

Handbook of Cancer Chemotherapy
Handbook of Cancer Chemotherapy

Author: Roland T. Skeel

Publisher: Lippincott Williams & Wilkins

Published: 2011

Total Pages: 896

ISBN-13: 160831782X

DOWNLOAD EBOOK

Skeel's Handbook of Cancer Chemotherapy combines in one place the most current rationale and specific details necessary to safely administer chemotherapy for most adult cancers. The handbook is a practical, diseased-focused pocket reference that emphasizes the best current medical practice as it relates to the delivery of chemotherapeutic drugs. By focusing on specific plans for treatment, the book is an invaluable resource for the daily care of cancer patients.

Waldenström’s Macroglobulinemia
Waldenström’s Macroglobulinemia

Author: Véronique Leblond

Publisher: Springer

Published: 2016-10-06

Total Pages: 361

ISBN-13: 3319225847

DOWNLOAD EBOOK

This book sheds new light on clinical, biological and therapeutic data on the rare disease Waldenström’s Macroglobulinemia (WM) with the participation of widely-recognized experts, involved in this field. It represents the efforts of physicians, scientists and patients, all around the world, to better understand and cure this rare disease. Considerable advances in the diagnosis, treatment indications, response criteria, prognostic factors and treatment options have been made since Dr Jan Waldenström first reported this “new syndrome“ 70 years ago. Particularly instrumental in advancing of our understanding of WM have been the eight international workshops devoted to this disease. New, exciting molecular data have recently been reported, allowing us to revisit the oncogenic events leading to WM B-cell proliferation and to use newly available compounds targeting oncogenic pathways.